WXXWY fundamentals
An in-depth look to Wuxi Biologics (Cayman) Inc operating, investing, and financing activities
WXXWY free cash flow for H2 23 is 38.52 M USD. For 2023, WXXWY free cash flow was 63.17 M USD and operating cash flow was 658.86 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM